ENNATURE BIO PHARMA LTD (ENNATURE) financials

ENNATURE BIO PHARMA LTD (ENNATURE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

ENNATURE BIO PHARMA LTD (ENNATURE) financials: Market Cap ₹375Cr., Price ₹168, P/E 49.3, ROE %. Sep 2026: sales ₹78.46 Cr, net profit ₹4.89 Cr. Quarterly resul…

  • Market Cap: ₹375Cr.
  • Current Price: ₹168
  • Stock P/E: 49.3
  • ROE: %
  • ROCE: %
  • Book Value: ₹
  • Dividend Yield: 0.00%
  • 52W High / Low: ₹275/165

In Sep 2026, ENNATURE BIO PHARMA LTD (ENNATURE) reported sales ₹78.46 Cr and net profit ₹4.89 Cr.

Annual Mar 2026: sales ₹246 Cr, net profit ₹1 Cr.

Shareholding: Promoters 59.63% (Nov 2026), FIIs 2.44% (Nov 2026), DIIs 4.61% (Nov 2026), Public 33.33% (Nov 2026), No. of Shareholders 48,292% (Nov 2026).

ENNATURE quarterly results (₹ Cr.)
CategorySep 2025Jun 2026Sep 2026
Sales54.1490.3978.46
YoY Sales growth——+44.92%
Expenses48.1080.4068.12
Operating Profit6.049.9910.34
OPM %11.16%11.05%13.18%
Other Income0.000.000.00
Interest3.790.040.03
Depreciation3.613.703.70
Profit before tax-1.366.256.61
Tax %-5.88%25.44%26.17%
Net Profit-1.284.664.89
EPS in Rs-640.002,330.002.19
Raw PDF———
ENNATURE profit and loss (₹ Cr.)
CategoryMar 2026
Sales246
Sales growth—
Expenses217
Operating Profit29
OPM %12%
Other Income-0
Interest13
Depreciation14
Profit before tax2
Tax %23%
Net Profit1
EPS in Rs605.00
Dividend Payout %0%
ENNATURE balance sheet (₹ Cr.)
CategorySep 2026
Equity Capital11
Reserves521
Borrowings0
Other Liabilities173
Total Liabilities705
Fixed Assets537
CWIP11
Investments0
Other Assets157
Total Assets705
ENNATURE cash flows (₹ Cr.)
CategoryMar 2026
Cash from Operating Activity—
Cash from Investing Activity—
Cash from Financing Activity—
Net Cash Flow—
Free Cash Flow—
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit—
ENNATURE shareholding pattern (%)
CategoryNov 2026
Promoters59.63%
FIIs2.44%
DIIs4.61%
Public33.33%
No. of Shareholders48,292
ENNATURE key ratios
CategoryMar 2026
Debtor Days—
Inventory Days—
Days Payable—
Cash Conversion Cycle—
Working Capital Days—
ROCE %—
ENNATUREUpdated 21 Nov 2026, 3:20

Ennature Bio Pharma Ltd

Market Cap

₹375Cr.

Current Price

₹168

High / Low

₹275/165

Stock P/E

49.3

Book Value₹
Dividend Yield0.00%
ROCE%
ROE%
Face Value₹5.00

About

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Nov 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2026
Debtor Days—
Inventory Days—
Days Payable—
Cash Conversion Cycle—
Working Capital Days—
ROCE %—

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ENNATURE BIO PHARMA LTD (ENNATURE)?

The reported market capitalisation for ENNATURE BIO PHARMA LTD (ENNATURE) is ₹375Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ENNATURE?

The current price shown for ENNATURE BIO PHARMA LTD (ENNATURE) on Fincrux is ₹168 with a 52-week high/low of ₹275/165.

What is the P/E ratio of ENNATURE BIO PHARMA LTD (ENNATURE)?

The stock P/E for ENNATURE BIO PHARMA LTD (ENNATURE) is 49.3 on Fincrux, with ROE at % and ROCE at %.

What were ENNATURE latest quarterly results?

For Sep 2026, ENNATURE BIO PHARMA LTD (ENNATURE) reported sales ₹78.46 Cr and net profit ₹4.89 Cr (figures in ₹ crore unless noted).

What are ENNATURE annual sales and net profit?

For Mar 2026, ENNATURE BIO PHARMA LTD (ENNATURE) shows sales of ₹246 Cr and net profit of ₹1 Cr on the Fincrux profit & loss statement.

Who owns ENNATURE BIO PHARMA LTD (ENNATURE)?

Latest shareholding for ENNATURE BIO PHARMA LTD (ENNATURE) on Fincrux: Promoters 59.63% (Nov 2026), FIIs 2.44% (Nov 2026), DIIs 4.61% (Nov 2026), Public 33.33% (Nov 2026), No. of Shareholders 48,292% (Nov 2026).

Where can I find ENNATURE BIO PHARMA LTD (ENNATURE) financials?

ENNATURE BIO PHARMA LTD (ENNATURE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ENNATURE balance sheet and cash flow?

Yes. The ENNATURE BIO PHARMA LTD (ENNATURE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.